On April 25, Weigao endocardial consumables group held a business invitation meeting on the listing of xinsorb absorbable coronary stent with the theme of "heart returning to nature, auspicious Hua'an" at Weihaiwei building. More than 100 partners from all over the country attended the meeting。

The meeting was presided over by Yan Dong, marketing director of Weigao consumables group. In the morning meeting, sun Fengwei, general manager of Weigao endocardial consumables group, delivered a speech, introducing the development history, industry status and future product layout planning of Weigao group and intracardiac consumables group. Weigao endocardial group will take cardiovascular intervention, nerve intervention and peripheral intervention consumables as the development direction, based on the domestic market, enter the international market, and become the first-class in the industry Influential companies in China。

Xie Jian, general manager of Shandong Hua'an company, reviewed the whole process of Huaan company and Xinxiang bio absorbable coronary stent from R & D project approval to marketing approval, and emphatically interpreted the clinical data of xinsorb absorbable stent. The results of data analysis showed that xinsorb stent is a biological absorbable stent with good clinical prognosis and high safety factor. Wei Zheng, deputy general manager of Hua'an company, and Zheng Guowei, marketing manager of Weigao xinnei consumables group, respectively made a detailed presentation on the process, model, validity period, supporting force, transportation and storage conditions, use principles and precautions of xinsorb absorbable stent, and answered the questions of participants。

At the meeting in the afternoon, Quan Yi Zhong, vice president of marketing of weigaoxin consumables group, announced the business policy of xinsorb bio absorbable stent. After that, the senior management team of weigaoxin consumables group had a positive interaction with the participants, and they had a full communication on how to better carry out cooperation and promote the listing and sales of xinsorb absorbable stent Everyone's warm applause ended successfully。

Yan Dong, marketing director of Weigao consumables group, presided over the meeting

Welcome speech by sun Fengwei, general manager of Weigao heart consumables group

Xie Jian, general manager of Shandong Hua'an company, introduced the clinical data of Hua'an company and xinsorb stent

Quan Yi Zhong, vice general manager of marketing of Weigao consumables group

Sun Fengwei, general manager of Weigao consumables group, actively interacts with participants